Articles From: Allot ServiceProtector Selected by Five Tier-1 Operators to Secure High Capacity Networks from Evolving Cyber Security Threats to Ligand Partner Pfizer Receives European Marketing Authorization for DUAVIVE® (Conjugated Estrogens/Bazedoxifene) for Treatment of Estrogen Deficiency Symptoms in Postmenopausal Women with a Uterus


2014/12/8
Allot's Anti-DDoS and spam control capabilities helps service providers protect their data networks HOD HASHARON, Israel , December 8, 2014 /PRNewswire/ -- Allot Communications Ltd.
Sign-up for Allot ServiceProtector Selected by Five Tier-1 Operators to Secure High Capacity Networks from Evolving Cyber Security Threats investment picks
Tremor Video, Inc. (NYSE:TRMR), an advertising technology company elevating brand performance across all screens for the world’s leading brands and publishers, Advertising Age, the leading media brand for advertising, marketing and media news, and Creativity, the brand world’s daily destination for the most important and exciting creative work being done in advertising, design and digital creativity around the globe, today announced the winners of the Third Annual Super Creative Video Ad Challenge .
Sign-up for Tremor Video and Advertising Age/Creativity Announce Winners of Third Annual Super Creative Video Ad Challenge investment picks
By Devlin Barrett and Byron Tau President Barack Obama criticized Sony Pictures Friday for pulling a movie out of theaters in response to a hack attack U.S. officials blame on North Korea, saying it sets a bad precedent and could encourage further censorship.
Sign-up for Obama says Sony 'made a mistake' cancelling film investment picks
2014/11/13
By Devlin Barrett The Justice Department is scooping up data from thousands of cellphones through fake communications towers deployed on airplanes, a high-tech hunt for criminal suspects that is snagging a large number of innocent Americans, according to people familiar with the operations.
Sign-up for Americans' cellphones targeted in secret spy program investment picks
SHANGHAI , Nov.
Sign-up for JinkoSolar Announces Third Quarter 2014 Financial Results investment picks
2015/1/9
By Dhanya Ann Thoppil BANGALORE, India-- Infosys Ltd.
Sign-up for Infosys Profit Rises 13% -- Update investment picks
2015/1/9
By Dhanya Ann Thoppil BANGALORE, India--Infosys Ltd.
Sign-up for Infosys Profit Rises 13% investment picks
2015/1/16
By Dhanya Ann Thoppil BANGALORE, India--Wipro Ltd.
Sign-up for Wipro Oct-Dec Net Profit Rises 8.8% investment picks
2015/1/7
By Dhanya Ann Thoppil Infosys Ltd., India's second-largest software exporter by sales, is scheduled to announce its fiscal third-quarter earnings during trading hours Friday.
Sign-up for Infosys Profit, Revenue Seen Rising in 3Q -- Earnings Preview investment picks
2015/1/15
By Dhanya Ann Thoppil Wipro is scheduled to announce its fiscal-third quarter earnings after market hours Friday.
Sign-up for Strong Dollar, Weak Energy Business May Weigh on Wipro's 3Q Results -- Earnings Preview investment picks
2014/11/20
By Diana Furchtgott-Roth, MarketWatch The retailer's GoBank service would benefit from documented newcomers How large is the potential market for Wal-Mart's new foray into banking?
Sign-up for UPDATE: How Obama's plan on immigration will enrich Wal-Mart investment picks
2015/1/21
By Diana Furchtgott-Roth, MarketWatch Americans are interested in tax cuts, not hikes You have to hand it to President Obama.
Sign-up for UPDATE: Obama's joke of a tax plan only fuels class warfare investment picks
2015/1/21
By Diana Furchtgott-Roth, MarketWatch The president seems to be more interested in inducing class warfare You have to hand it to President Obama.
Sign-up for UPDATE: Obama is decidedly unserious with his tax-increase plans investment picks
2014/12/23
By Diana Furchtgott-Roth, MarketWatch Even though I picked large, solid companies, they couldn't outperform broad indexes At this time last year I wrote in a column: "With the stock market achieving record highs at the end of 2013, some might think it is time to take their winnings and go into cash.
Sign-up for UPDATE: What I learned with my 10 stock recommendations a year ago investment picks
Omnicell Solution Enables Pharmacists to Directly Impact Patients' Quality of Life ORLANDO, Fla.
Sign-up for Omnicell Launches Its First Fully Automated Multimed Packing Solution, Driving Workflow Efficiency, Patient Adherence, and Pharmacy Growth investment picks
2014/10/29
By Dinny McMahon BEIJING --
Sign-up for China eases monopoly on handling credit-card payments investment picks
2015/1/11
By Dion Nissenbaum and Colleen McCain Nelson WASHINGTON--Attorney General Eric Holder said on Sunday the U.S. and its allies are working to determine if al Qaeda in the Arabian Peninsula played a direct role in orchestrating last week's attacks in Paris before deciding whether to retaliate against the militants in the Middle East.
Sign-up for Holder Says U.S., Allies Probing Terror Group Links to Paris Attacks investment picks
2014/12/8
- 2015 Estimated 7 - 11% Underlying Sales Growth and Adjusted EPS of $3.90 - $4.10 - Pipeline of Innovative Technologies Positions Company for Sustainable Growth NEW YORK , Dec.
Sign-up for Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference investment picks
Generates $56 Million in Restructuring-Related Annual Cost Savings; Anticipates Sequential Revenue Growth in the December Quarter IRVINE, Calif.
Sign-up for MFLEX Returns To Profitability - Reports Fiscal 2014 Fourth Quarter Financial Results investment picks
- Total Sales Grew Approximately 20% - Global THV Sales Grew 44% (Underlying); 55% (GAAP) - Full Year 2014 Sales and EPS Guidance Raised IRVINE, Calif.
Sign-up for Edwards Lifesciences Reports Third Quarter Results investment picks
Fourth Quarter Results Include: - Net Sales of $303.3 Million, Up 3.8 Percent Sequentially and 21.1 Percent Over Prior Year - Gross Margin of 56.4 Percent - GAAP Diluted Earnings per Share of $0.34 - Non-GAAP Diluted Earnings per Share of $0.64 - Operating Cash Flow of $59.6 Million ALISO VIEJO, Calif.
Sign-up for Microsemi Reports Fourth Quarter and Fiscal Year 2014 Results investment picks
ANGLETON, Texas , Oct.
Sign-up for Benchmark Electronics Results Exceed Third Quarter Guidance investment picks
First Solar, Inc. (Nasdaq: FSLR) and BELECTRIC today announced that they have broken ground on a new 46 megawatt (MW DC ) utility-scale power plant, in Oxfordshire, Southern England.
Sign-up for First Solar, BELECTRIC to Add 45 Million kWh of Clean Electricity to UK Generation Portfolio investment picks
2014/11/5
Tiny Prints, the leading online stationery boutique, today unveils its exclusive holiday charity card collection , a percentage of which will benefit Baby2Baby , a non-profit organization that provides low-income children, ages zero to 12, with diapers, clothing and all the basic necessities that every child deserves.
Sign-up for Tiny Prints Gives Back This Holiday Season with an Exclusive Holiday Card Collection Benefiting Non-Profit Baby2Baby investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner GlaxoSmithKline (GSK) plc reported the submission to the European Medicines Agency (EMA) of a variation to the Marketing Authorization for Revolade™ (eltrombopag), seeking an additional indication for the treatment of adult patients with severe aplastic anemia (SAA) who have had an insufficient response to immunosuppressive therapy (IST). SAA is a rare disorder in which the bone marrow fails to make enough new blood cells.
Sign-up for Ligand Partner GlaxoSmithKline Announces EU Regulatory Submission for Severe Aplastic Anemia Indication for Revolade™ (eltrombopag) investment picks
At an Analyst Day event held earlier today in New York City, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) reviewed the financial leverage in its business model, revenue growth opportunities and its portfolio of partnered assets and unpartnered development programs, as well as its Captisol formulation technology and its financial outlook through 2017.
Sign-up for Ligand Provides Highlights from Today’s Analyst Day Event investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced that its partner GlaxoSmithKline (GSK) plc reported the submission of a supplemental New Drug Application (sNDA) to the US Food and Drug Administration for eltrombopag (Promacta), seeking an additional indication in pediatric patients six years old and older with chronic immune (idiopathic) thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy.
Sign-up for Ligand Partner GlaxoSmithKline Announces US Regulatory Submission Seeking Additional Indication for Promacta® investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that its partner Spectrum Pharmaceuticals (NASDAQ: SPPI) has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Captisol-enabled™ Melphalan (CE-Melphalan) HCl for injection (propylene glycol-free) for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma.
Sign-up for Ligand Partner Spectrum Pharmaceuticals Announces Submission of New Drug Application for Captisol-Enabled™ Melphalan investment picks
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner Pfizer has received EU marketing authorization for DUAVIVE® (conjugated estrogens/bazedoxifene (BZA/CE)) from the European Commission.
Sign-up for Ligand Partner Pfizer Receives European Marketing Authorization for DUAVIVE® (Conjugated Estrogens/Bazedoxifene) for Treatment of Estrogen Deficiency Symptoms in Postmenopausal Women with a Uterus investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Allot ServiceProtector Selected by Five Tier-1 Operators to Secure High Capacity Networks from Evolving Cyber Security Threats to Ligand Partner Pfizer Receives European Marketing Authorization for DUAVIVE® (Conjugated Estrogens/Bazedoxifene) for Treatment of Estrogen Deficiency Symptoms in Postmenopausal Women with a Uterus
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent